β-Lactam derivatives as potential anti-cancer compounds
- 9 June 2008
- journal article
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 139 (7) , 847-857
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Synthesis of anticancer β-lactams: mechanism of actionBioorganic & Medicinal Chemistry, 2004
- Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue designBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis of antitumor 6-alkylidenepenicillanate sulfones and related 3-alkylidene-2-azetidinonesBioorganic & Medicinal Chemistry Letters, 2004
- Novel N-thiolated β-lactam antibiotics selectively induce apoptosis in human tumor and transformed, but not normal or nontransformed, cellsBiochemical Pharmacology, 2004
- β-Lactam Derivatives as Enzyme Inhibitors: Carboxy Peptidyl Derivatives of (S)-4-Oxoazetidine-2-carboxylate as PeptidomimeticsArchiv der Pharmazie, 2001
- 7-Alkylidenecephalosporin Esters as Inhibitors of Human Leukocyte ElastaseJournal of Medicinal Chemistry, 1997
- Recent Advances in the .beta.-Lactam Synthon MethodAccounts of Chemical Research, 1995
- Orally Active .beta.-Lactam Inhibitors of Human Leukocyte Elastase. 3. Stereospecific Synthesis and Structure-Activity Relationships for 3,3-Dialkylazetidin-2-onesJournal of Medicinal Chemistry, 1995
- 3-(Prop-2-enylidene)azetidin-2-one Derivatives: Synthesis, structure, and formation of 3-spiro-?-lactamsvia Diels-Alder reactionsHelvetica Chimica Acta, 1995
- Dicarboxylates of 3‐Methylidene‐β‐lactams: Addition Reactions to the Exocyclic Double Bond, Formation of Spiro‐β‐lactams, and Reductive Ring Opening by HydrazinesHelvetica Chimica Acta, 1993